tiprankstipranks
Tharimmune (THAR)
NASDAQ:THAR
US Market

Tharimmune (THAR) Technical Analysis

55 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
2Neutral
11Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
5Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Tharimmune’s (THAR) Moving Averages Convergence Divergence (MACD) indicator is -0.17, suggesting Tharimmune is a Sell.
Tharimmune’s (THAR) 20-Day exponential moving average is 3.61, while Tharimmune’s (THAR) share price is $4.07, making it a Buy.
Tharimmune’s (THAR) 50-Day exponential moving average is 4.35, while Tharimmune’s (THAR) share price is $4.07, making it a Sell.

Tharimmune (THAR) Pivot Points

Jul 17, 2024, 02:47 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.27
3.41
3.61
3.75
3.95
4.09
4.29
Fibonacci
3.41
3.54
3.62
3.75
3.88
3.96
4.09
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Tharimmune (THAR) Moving Averages

Jul 17, 2024, 02:47 PM
Period
Simple
Exponential
MA5
3.65Buy
3.68Buy
MA10
3.53Buy
3.57Buy
MA20
3.32Buy
3.61Buy
MA50
4.40Sell
4.35Sell
MA100
5.18Sell
8.81Sell
MA200
19.97Sell
29.17Sell
Tharimmune’s (THAR) 10-Day exponential moving average is 3.57, while Tharimmune’s (THAR) share price is $4.07, making it a Buy.
Tharimmune’s (THAR) 100-Day exponential moving average is 8.81, while Tharimmune’s (THAR) share price is $4.07, making it a Sell.
Tharimmune’s (THAR) stock price is $4.07 and Tharimmune’s (THAR) 50-day simple moving average is 4.40, creating a Sell signal.
Tharimmune’s (THAR) stock price is $4.07 and Tharimmune’s (THAR) 100-day simple moving average is 5.18, creating a Sell signal.
Tharimmune’s (THAR) stock price is $4.07 and Tharimmune’s (THAR) 200-day simple moving average is 19.97, creating a Sell signal.

Tharimmune (THAR) Technical Indicators

Jul 17, 2024, 02:47 PM
Name
Value
Implied Action
RSI (14)
52.27
Neutral
STOCH (9,6)
81.75
Sell
STOCHRSI (14)
88.35
Sell
MACD (12,26)
-0.17
Sell
ADX (14)
15.81
Buy
Williams %R
-7.76
Sell
CCI (14)
173.22
Sell
ATR (14)
0.32
-
Ultimate Oscillator
51.39
Neutral
ROC
36.17
Buy
Tharimmune’s (THAR) Relative Strength Index (RSI) is 52.27, creating a Neutral signal.
Tharimmune’s (THAR) Trend Strength Indicator (ADX) is 15.81, creating a Buy signal.
Tharimmune’s (THAR) Commodity Channel Index (CCI) is 173.22, creating a Sell signal.
Tharimmune’s (THAR) Price Rate of Change (ROC) is 36.17, creating a Buy signal.

FAQ

Is THAR a Buy, Hold, or Sell?
Based on THAR’s technical indicators, THAR is a Hold.
    What is THAR’s RSI (14)?
    THAR’s RSI (14) is 52.27, which suggests THAR is a Neutral.
      What is THAR’s MACD?
      THAR’s MACD is -0.17, which suggests THAR is a Sell.
        What is THAR’s 5-day moving average?
        THAR’s 5-day moving average is 3.65, which suggests THAR is a Buy.
          What is THAR’s 20-day moving average?
          THAR 20-day moving average is 3.32, which suggests THAR is a Buy.
            What is THAR’s 50-day moving average?
            THAR’s 50-day moving average is 4.40, which suggests THAR is a Sell.
              What is THAR’s 200-day moving average?
              THAR’s 200-day moving average is 19.97, which suggests THAR is a Sell.
                What is THAR’s Williams % R (14)?
                THAR’s Williams % R (14) is -7.76, which suggests THAR is a Sell.
                  What is THAR’s CCI (14)?
                  THAR’s CCI (14) is 173.22, which suggests THAR is a Sell.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis